A detailed history of Bank Of Montreal transactions in Medicinova Inc stock. As of the latest transaction made, Bank Of Montreal holds 132,230 shares of MNOV stock, worth $277,683. This represents 0.0% of its overall portfolio holdings.

Number of Shares
132,230
Holding current value
$277,683
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.28 - $1.57 $169,254 - $207,601
132,230 New
132,230 $190,000
Q2 2023

Aug 02, 2023

BUY
$2.09 - $2.43 $266,057 - $309,339
127,300 New
127,300 $292,000

Others Institutions Holding MNOV

About MEDICINOVA INC


  • Ticker MNOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,046,200
  • Market Cap $103M
  • Description
  • MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...
More about MNOV
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.